{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-006510","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2024-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.624106+00:00","generated_at":"2026-06-06T20:09:54.994920+00:00","sec_items":["3.03","5.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Revelation Biosciences effects 1-for-30 reverse stock split, ~210K shares outstanding","bullets":["Stockholders approved reverse split at Jan 17 special meeting; board set ratio at 1-for-30.","Reverse split effective 12:01 a.m. ET on Jan 25, 2024; common stock continues trading under REVB.","Post-split shares outstanding ~209,911; no fractional shares, rounding up to whole shares.","Outstanding equity awards and warrants proportionally adjusted for the 1-for-30 ratio.","New CUSIP for common stock: 76135L507."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-006510","json":"https://secwatch.observer/filing/0000950170-24-006510.json","markdown":"https://secwatch.observer/filing/0000950170-24-006510.md","text":"https://secwatch.observer/filing/0000950170-24-006510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024006510/0000950170-24-006510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024006510/revb-20240122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:09:54.994920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"45b28d77b25750c62bdd367479a0f9cea97164dc","claim":"REVELATION BIOSCIENCES, INC.: Filed Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation to effect a 1-for-30 reverse stock split, effective January 25, 2024 (effective 2024-01-25).","evidence_excerpt":"On January 22, 2024, the Company filed a Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) effecting a reverse stock split as of 12:01 a.m. Eastern Standard Time on January 25, 2024 with a ratio of 1-for-30 (the “Reverse Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024006510/0000950170-24-006510-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-25"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}